Gene Query: LRRC20

Dataset Description Geneva Score
A role for ZNF598 in post-transcriptional gene regulation 58.7
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 58.03
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 37.61
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 35.05
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 31.4
Gene Expression Profiling of SPOP Knocked Down Cell 30.14
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 28.81
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 27.49
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 26.74
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 25.9
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 25.58
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 23.76
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 22.26
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 22.26
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 20.3
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 20.22
hTERT promotes cell adhesion and migration independent of telomerase activity 19.65
Nucleoporin-mediated regulation of cell identity genes 18.21
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 18.06
Altering cancer transcriptomes using epigenomic inhibitors 18.06
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 17.45
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 17.45
Transcriptional responses of human insulinoma cells to acute cytokine exposure 16.89
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 16.69
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 16.69
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.2
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.2
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 15.9
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 15.9
Glioblastoma stem cells infected by ZIKA virus 15.77
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 15.25
Survival of pancreatic cancer cells lacking KRAS function 14.95
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 14.52
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 13.6
Transcriptomic analysis of LSD1 13.46
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 13.37
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 13.24
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 13.11
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 13.11
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 12.75
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.66
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 12.56
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 12.56
Androgen Receptor-regulated genes in prostate cancer cells 12.55
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 12.55
Gene expression changes after LOC550643 silencing 12.29
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 11.8
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 11.76
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 11.75
N6-methyladenine DNA Modification in Glioblastoma 11.6
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 11.6
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 11.06
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.55
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.55
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 10.23
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 10.15
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 9.87
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 9.72
Comparing gene expression in iPSC derived RPE from control and AMD donors 9.7
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 9.58
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 9.52
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 9.34
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 9.11
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 8.94
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.54
Effect of CHKA knockdown on C4-2 cell transcriptome 8.51
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 8.39
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 8.38
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.14
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.14
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 7.82
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 7.58
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 7.58
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.55
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 7.41
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 7.41
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 7.38
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 7.38
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.35
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.35
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.31
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.27
RNA-seq analysis of control and Myc-induced U2OS cells 7.22
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.13
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.12
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.87
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 6.77
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 6.77
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.72
RNA-Seq analysis of breast cancer cells after shikonin treatment 6.62
TGF-β promotes genomic instability after loss of RUNX3 6.6
METTL3 promotes translation in human cancer cells 6.53
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.48
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 6.43
Genome-wide functional assessment of enhancer activities in the human genome 6.32
AUF-1 affected genes in human skin cells 6.28
Evolution of a transcriptional regulator from a transmembrane nucleoporin 6.28
RNA-seq in HepG2 and IMR90 cells 6.28
MYCi361 regulates MYC target genes 6.2
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.93
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 5.91
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.86
Transcriptome-wide identification of CELF2 functional targets in T cells 5.79
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 5.77
Transcriptome profiling of Normal and Cancerous Prostate Cells 5.72
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 5.71
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 5.68
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 5.66
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 5.66
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 5.6
Transcriptional changes in lymphoma cells induced by LSD1 depletion 5.6
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.57
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 5.49
Iron response of HepG2 cells 5.47
RNA-seq analyses of human prostate cancer cells 5.38
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 5.33
Effects of transcription on genome - nuclear lamina interactions 5.33
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 5.3
A code of mono-phosphorylation modulates the function of RB. 5.25
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 5.25
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.21
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.21
Silencing SPIB in attached and floating state of H1703 lung cancer cells 5.19
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 5.16
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 5.16
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.94
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.92
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 4.91
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 4.89
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.88
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.83
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 4.73
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 4.73
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 4.72
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.7
Gene expression profile in breast cancer cells 4.7
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.66
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 4.66
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.66
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 4.64
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 4.59
Neurofibroma 4.59
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 4.59
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.59
Dynamic 3D chromosomal landscapes in acute leukemia 4.59
The effect of PPARG inhibition on human angiomyolipoma cells 4.58
Transcriptome of human white and brown adipose tissue biopsies 4.55
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.55
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.54
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 4.54
Expression charcaterization of an internal protocol developed to differentiate RPE cells 4.48
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.43
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 4.42
Downregulation of DDX5/DDX17 and REST 4.4
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 4.38
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.35
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.33
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 4.32
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.31
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 4.3
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 4.3
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 4.19
HNRNPL and its RNA Targets in Prostate Cancer 4.18
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 4.18
CDK12 mediated transcriptional regulation in U2OS cells 4.14
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.14
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.09
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.05
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.03
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 4.01
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 3.99
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.98
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 3.97
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 3.97
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.96
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.95
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 3.95
Functional role of CPPED1 in trophoblasts. 3.95
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 3.92
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.91
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.9
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.88
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 3.88
The landscape of alternative splicing in aggressive prostate cancers 3.86
Lipid degradation promotes prostate cancer cell survival 3.83
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 3.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.81
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.81
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 3.79
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.78
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 3.78
Analysis of transcriptional regulation by Myt1 and Myt1l 3.77
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.69
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.67
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.66
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.65
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.63
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.58
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.58
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.58
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 3.56
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.55
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.55
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.53
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.51
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.5
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.5
SNHG5 siRNA knock down in HCT116 cells 3.48
Identification of Nrf2 regulated genes by RNA sequencing 3.47
Nrf2 regulated genes in A549 cells 3.47
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 3.44
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.42
Functional role of SLIT2 and ROBO1 in trophoblasts 3.41
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.41
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.41
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.39
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.39
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.38
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.37
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 3.35
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.35
R430: A potent inbibitor of DNA and RNA viruses 3.34
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 3.34
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.33
Transcriptome analysis of U87 cells upon LINC00152 knockdown 3.33
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.3
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.3
Maturation of human iNSCs 3.29
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.27
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.26
TCF7L1 knockdown in pancreatic cancer 3.25
Effect of Influenza virus infection on lncRNA expression in A549 cells 3.24
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 3.22
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.22
KSDM1b Role in Ewing Sarcoma 3.22
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.22
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 3.21
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 3.21
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 3.21
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.18
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 3.17
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 3.17
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 3.16
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 3.15
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.15
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.14
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.12
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.09
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.08
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.02
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.99
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.99
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.99
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.99
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.99
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.99
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.97
Gene expression profiling of leukemia cells following asparagine depletion 2.97
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.91
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.91
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.91
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.89
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.89
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 2.88
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 2.87
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 2.87
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.86
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.86
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 2.86
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.84
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.81
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 2.78
Paxillin regulates genomic networks in prostate cancer [PC3] 2.76
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.76
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.76
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.75
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.75
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.71
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.7
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.69
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.68
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.68
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.66
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.64
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.64
RNA seq comparison between scrambled and shGRP78 cells 2.62
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.6
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.59
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.59
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 2.59
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 2.59
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.58
CSL RNA-Seq on HKC and SCC cell lines 2.58
CSL 2.58
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.57
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.56
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.56
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.52
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.52
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.52
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.52
Identification of HOXB13 target genes responsive to BET inhibitors 2.5
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.49
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 2.49
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.47
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.47
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.46
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.45
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.45
Regulation of hypoxia-inducible factor activity by ZMYND8 2.4
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.4
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 2.39
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.38
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.36
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.36
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.34
Fusion discovery in breast cancer cell line 2.32
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.31
The cohesin complex prevents Myc-induced replication stress 2.26
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.24
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 2.23
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.23
HNRNPM-regulated splicing dependencies in prostate cancer 2.23
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.22
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 2.21
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 2.21
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.15
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.14
Effect of Hotair overexpression in human breast cancer cell lines 2.13
Gene expression and genome-wide location analysis of breast cancer cell-lines 2.12
Gene expression analysis of breast cancer cell-lines 2.12
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.11
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.09
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.09
Alagille_Nodder 2.08
RNA Seq of Alagille liver biopsies 2.08
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.07
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.07
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.07
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.07
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.06
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.06
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.06
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.06
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.06
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.05
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.03
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 2.03
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.02
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.97
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.97
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.96
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.95
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.94
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.94
Effect of nuclear IL-33 on gene expression 1.93
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.93
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.89
Global epigenomic reconfiguration during mammalian brain development 1.88
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.86
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.8
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.8
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 1.76
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.76
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.75
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.75
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.69
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.68
Identification of global XBP1s target gene expression in human prostate cancer cells 1.63
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.61
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.59
Gene expression profile in breast cancer cell lines using RNA sequencing 1.59
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.56
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.55
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.53
Gene profiling of human adult and pediatric liver cancer cells 1.47
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.44
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.4
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.4
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.4
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.4
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 1.39
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.37
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 1.37
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 1.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.35
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.35
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.35
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.32
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.3
Effect of PBK knockdown on C4-2 cell transcriptome 1.3
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.29
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.29
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.28
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.27
p53 activity results in DNA replication fork processivity 1.26
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.26
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.25
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.25
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.23
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.23
Exploring ILF2 regulatory genes by next-generation sequencing 1.23
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.23
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.22
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.21
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.21
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.21
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.2
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.2
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.18
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.18
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.14
Induced DNA demethylation, genome instability and transcription 1.06
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.06
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.04
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.04
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 1.04
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.99
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.96
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.96
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.96
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.94
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.93
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.92
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.91
Functional significance of the HIV-1 Tat signature amino acid residues 0.9
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.89
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.87
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.85
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.83
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.83
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.81
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.79
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.76
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.73
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.73
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.72
Oncogenic roles of ARID5B in T-ALL 0.71
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.71
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 0.71
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.66
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.65
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.64
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.64
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.62
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.6
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.59
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.58
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.55
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.53
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.53
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.53
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.51
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.5
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.49
Dilated cardiomyopathy vs Myocarditis 0.46
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.45
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.45
Myc activation coordinates gene transcription and protein translation responses 0.45
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.41
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.4
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.4
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.4
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.39
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.38
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.37
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.34
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.34
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.33
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.33
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.33
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.31
Expression profiles of the four human major ectodermal lineages 0.28
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.26
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.24
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.23
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.23
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.2
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.2
Role of FGFR1 in neuronal devlopment 0.19
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 0.18
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.18
H1609088 Human RNA-Sequencing 0.18
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.16
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.15
Gene expression of thyroid cancer cell lines 0.13
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.12
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.1
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.09
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.08
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.04
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.03
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.03
Modeling Human Cancer-induced Cachexia (Human) 0.03
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.02
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation